Nucleoside diphosphate kinase (NDP kinase; ATP: NDP phosphotransferase; EC 2.7.4.6) was purified from bovine retina. The molecular mass of the native enzyme was found to be 72 kDa, and those of its subunits were 17.5 and 18.5 kDa. Kinetic characteristics of the enzyme were determined. It was shown that NDP kinase exists in retina in both soluble and membrane-bound forms.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Insights into the Activation and Self-Association of Arrestin-1.
Biochemistry
December 2024
Gavin Herbert Eye Institute - Center for Translational Vision Research, Department of Ophthalmology, University of California, Irvine, Irvine, California 92697, United States.
Arrestins halt signal transduction by binding to the phosphorylated C-termini of activated G protein-coupled receptors. Arrestin-1, the first subtype discovered, binds to rhodopsin in rod cells. Mutations in , the gene encoding Arrestin-1, are linked to Oguchi disease, characterized by delayed dark adaptation.
View Article and Find Full Text PDFMechanisms of amphibian arrestin 1 self-association and dynamic distribution in retinal photoreceptors.
J Biol Chem
December 2024
Center for Vision Research and the Department of Ophthalmology and Visual Sciences, SUNY Upstate Medical University, Syracuse, New York, USA. Electronic address:
Article Synopsis
- Visual arrestin 1 (Arr1) is crucial for stopping the light response in photoreceptors, and while its dimer and tetramer formations have been studied in mammals, similar research in amphibians is lacking.
- In this study, the dimerization of Arr1 from two amphibian species, Xenopus laevis and Ambystoma tigrinum, revealed that both proteins primarily form dimers with similar dissociation constants (K) to mammalian Arr1.
- Crystallography and other techniques identified two potential dimer structures for amphibian Arr1, suggesting that the interaction between dimer forms may influence their stability and that the distribution of Arr1 in dark-adapted photoreceptors is impacted by
Growth Hormone Neuroprotective Effects After an Optic Nerve Crush in the Male Rat.
Invest Ophthalmol Vis Sci
November 2024
Departamento de Neurobiología Celular y Molecular, Instituto de Neurobiología, Campus Juriquilla, Universidad Nacional Autónoma de México, Querétaro, Qro., México.
Purpose: Growth hormone (GH) has neuroprotective effects that have not been evaluated in the mammalian visual system. This study tested the hypothesis that GH administration can promote retinal neuroprotection in an optic nerve crush (ONC) model in male rats.
Methods: The ON was compressed for 10 seconds, and bovine GH was injected concomitantly to injury for 14 days (0.
Neuroprotective Actions of Hydrogen Sulfide-Releasing Compounds in Isolated Bovine Retinae.
Pharmaceuticals (Basel)
October 2024
Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Texas Southern University, Houston, TX 77004, USA.
We have evidence that hydrogen sulfide (HS)-releasing compounds can reduce intraocular pressure in normotensive and glaucomatous rabbits by increasing the aqueous humor (AH) outflow through the trabecular meshwork. Since HS has been reported to possess neuroprotective actions, the prevention of retinal ganglion cell loss is an important strategy in the pharmacotherapy of glaucoma. Consequently, the present study aimed to investigate the neuroprotective actions of HS-releasing compounds against hydrogen peroxide (HO)-induced oxidative stress in an isolated bovine retina.
View Article and Find Full Text PDFDo preterm infants' retinas like bovine colostrum? A randomized controlled trial.
Ital J Pediatr
October 2024
Pediatrics and Neonatology, Pediatric Department, Alexandria University Faculty of Medicine, Alexandria University, Alexandria, Egypt.
Article Synopsis
- Bovine colostrum (BC) delivered via a liposomal system was tested as a supplement for premature infants, aiming to reduce the incidence of retinopathy of prematurity (ROP) due to its multiple beneficial factors for retinal development.
- A controlled trial involving 211 preterm infants found that those receiving BC had a significantly lower incidence of ROP compared to those who did not receive it (5% vs. 16%), along with improved growth and lower rates of suspected sepsis.
- The study concluded that BC intake positively impacted health outcomes in preterm infants, particularly reducing ROP, enhancing hemoglobin levels, and contributing to weight gain, although weight gain was the strongest predictor of reduced ROP.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!